Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 8.72% and Operating profit at -1.32% over the last 5 years
Negative results in Mar 26
Stock is technically in a Mildly Bearish range
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
INR 1,296 Cr (Small Cap)
17.00
27
1.34%
-0.11
4.07%
0.76
Total Returns (Price + Dividend) 
Latest dividend: 13.816347753743761 per share ex-dividend date: Aug-14-2025
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Closure of Trading Window
31-Jul-2026 | Source : BSEPursuant to provisions of Regulation 29(1) of SEBI (LODR) Regulations 2015 notice is hereby given that a Meeting of Board of Directors of the Company will be held on Thursday 13th August 2026 inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2026. In continuation of our letter dated 26th June 2026 for closure of trading window for the aforesaid purpose the trading window for trading in Companys securities will continue to remain closed till 15th August 2026 pursuant to Companys Code of Conduct for Prevention of Insider Trading. The Trading window shall re-open on 16th August 2026. Accordingly all concerned to whom the above code is applicable are advised not to trade in the Companys securities during the period of closure of Trading window. The trading window will however be open for general investors.
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29(1) Of SEBI (LODR) Regulations 2015
31-Jul-2026 | Source : BSEExcel Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of SEBI(LODR) Regulations 2015 notice is hereby given that a Meeting of Board of Directors of the Company will be held on Thursday 13th August 2026 inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2025. In continuation of our letter dated 26th June 2026 for closure of trading window for the aforesaid purpose the Trading Window for trading in Companys securities will continue to remain closed till 15th August 2026 pursuant to the Companys Code of Conduct for Prevention of Insider Trading. The Trading Window shall re-open on 16th August 2026. Accordingly all concerned to whom the above said code is applicable are advised not to trade in the Companys securities during the period of closure of the Trading Window. The trading window will however be open for general investors.
Update on board meeting
31-Jul-2026 | Source : BSEExcel Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Update on board meeting - Pursuant to the provisions of Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 notice is hereby given that a Meeting of Board of Directors of the Company will be held on Thursday 13th August 2026 inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2026. In continuation of our letter dated 26th June 2026 for closure of trading window for the aforesaid purpose the Trading Window for trading in Companys securities will continue to remain closed till 15th August 2026 pursuant to the Companys Code of Conduct for Prevention of Insider Trading. The Trading Window shall re-open on 16th August 2026. Accordingly all concerned to whom the above said code is applicable are advised not to trade in the Companys securities during the period of closure of the Trading Window. The trading window will however be open for general investors.
Corporate Actions 
13 Aug 2026
Excel Industries Ltd has declared 275% dividend, ex-date: 14 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 4 Schemes (0.01%)
Held by 37 FIIs (1.86%)
Anshul Specialty Molecules Private Limited (42.92%)
Life Insurance Corporation Of India (6.69%)
30.64%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 20.42% vs -13.58% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 45.50% vs -60.17% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.60% vs 29.46% in Sep 2024
Growth in half year ended Sep 2025 is -17.62% vs 770.76% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 11.37% vs 23.22% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -13.05% vs 605.03% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.91% vs 18.39% in Mar 2025
YoY Growth in year ended Mar 2026 is -11.30% vs 401.53% in Mar 2025